0001104659-20-104516.txt : 20200911 0001104659-20-104516.hdr.sgml : 20200911 20200911190714 ACCESSION NUMBER: 0001104659-20-104516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200909 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kleiner Perkins Caufield & Byers XV, LLC CENTRAL INDEX KEY: 0001547840 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 201171955 BUSINESS ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 233-2750 MAIL ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KPCB XV Associates, LLC CENTRAL INDEX KEY: 0001547838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 201171956 BUSINESS ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 233-2750 MAIL ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KPCB XV Founders Fund, LLC CENTRAL INDEX KEY: 0001547839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 201171957 BUSINESS ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 233-2750 MAIL ADDRESS: STREET 1: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 tm2030740d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-09-09 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001547840 Kleiner Perkins Caufield & Byers XV, LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0001547838 KPCB XV Associates, LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0001547839 KPCB XV Founders Fund, LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 Common Stock 2020-09-09 4 J 0 650000 0 D 2597063 I By KPCB Holdings, Inc., as nominee Kleiner Perkins Caufield & Byers XV, LLC ("KPCB XV") made a pro rata distribution for no consideration to its members of 631,150 shares of common stock on September 9, 2020. KPCB XV Founders Fund, LLC ("KPCB XV FF") made a pro rata distribution for no consideration to its members of 18,850 shares of common stock on September 9, 2020. The shares are held for convenience in the name of KPCB Holdings, Inc., as nominee for the accounts of the following entities as follows: 2,521,749 shares held for the account of KPCB XV and 75,314 shares held for the account of KPCB XV FF. The managing member of KPCB XV and KPCB XV FF is KPCB XV Associates, LLC ("KPCB XV Associates"). Beth Seidenberg, L. John Doerr, Randy Komisar, Theodore E. Schlein, Wen Hsieh and William "Bing" Gordon, the managing members of KPCB XV Associates, exercise shared voting and dispositive control over the shares held by KPCB Holdings, Inc. as nominee for the accounts of KPCB XV and KPCB XV FF. KPCB XV Associates and each of its managing members disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that KPCB XV Associates or any of its managing members is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. /s/ Susan Biglieri, Chief Financial Officer 2020-09-11